Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease

Completed · Phase 2

Conditions studied: COVID-19

In brief

The aim of this study is to evaluate the effectiveness of MLS laser therapy as a treatment for pulmonary complications due to COVID-19 infection.

Key facts

Study ID

NCT04391712

Run by

Lowell General Hospital

People needed

10

Starts

2020-04-30

Expected to finish

2020-07-16

Last updated by the study team

2020-08-05

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• COVID-19 positive
• Pulmonary compromise requiring oxygen support of approximately 2-6 liters
• Able to self prone, or support in self-sitting position

You may not qualify if…

• Ventilator management
• Patients with autoimmune disorders or inflammatory conditions not related to COVID-19
• Pregnant women

Where it is running

• Lowell General Hospital — Lowell, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.